DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Apr 25, 2024 · 2y ago · Accession 0001628280-24-018138
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Apr 25, 2024
- Report date
- Apr 25, 2024
- Document
- cdxc-20240425.htm
- Size
- 2.7 MB